Stanislas Didierlaurent
LETI Pharma (Germany)(DE)
Publications by Year
Research Areas
Nitric Oxide and Endothelin Effects, Microbial Natural Products and Biosynthesis, Synthesis and biological activity, Receptor Mechanisms and Signaling, Synthesis and Catalytic Reactions
Most-Cited Works
- → Sulfonylureas and Sulfonylcarbamates as New Non-Tetrazole Angiotensin II Receptor Antagonists. Discovery of a Highly Potent Orally Active (Imidazolylbiphenylyl)sulfonylurea (HR 720)(1995)64 cited
- → Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure(2002)53 cited
- → Potent nonpeptide endothelin antagonists(2000)26 cited
- → Nonpeptide endothelin antagonists: from lower affinity pyrazol-5-ols to higher affinity pyrazole-5-carboxylic acids(2000)24 cited
- → An Expedient Synthesis of Ethyl 4(5)-Alkyl(aryl)thioimidazole-5(4)-carboxylate(1995)21 cited
- → Vinylogous vs arylogous isocephems(1993)3 cited
- → ChemInform Abstract: Sulfonylureas and Sulfonylcarbamates as New Non‐Tetrazole Angiotensin II Receptor Antagonists. Discovery of a Highly Potent Orally Active ( Imidazolylbiphenylyl)sulfonylurea (HR 720) (II).(1995)1 cited
- → ChemInform Abstract: Potent Nonpeptide Endothelin Antagonists: Synthesis and Structure—Activity Relationships of Pyrazole‐5‐carboxylic Acids.(2001)
- → ChemInform Abstract: Synthesis of Sub‐Micromolar Inhibitors of MraY by Exploring the Region Originally Occupied by the Diazepanone Ring in the Liposidomycin Structure.(2002)
- → ChemInform Abstract: An Expedient Synthesis of Ethyl 4(5)‐Alkyl(aryl)thioimidazole‐5(4)‐ carboxylate.(1995)